Division staff collected 28 samples of compounded preparations during FY2012, which represented 9 fewer samples (24% decrease) than were collected in FY2011. Although all of the sterile preparations collected in FY2012 sterile and free of endotoxins (100% sterility), test results show that 3 of the 28 collected samples (11%) failed to yield the acceptable potency results. See Ongoing Objective #2 for additional information.
quoted from 2012 Texas Board of Pharmacy Annual Report found here